Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days.
暂无分享,去创建一个
M. Zucchetti | C. Sessa | M. Borner | M. D’Incalci | A. Ronchi | C. Minoia | J. de Jong | O. Pagani | J. Bauer | M. D’lncalci | J. Renard | C. Weil | J. D. Jong